Renal Clearance of B-Type Natriuretic Peptide and Amino Terminal Pro-B-Type Natriuretic Peptide. A Mechanistic Study in Hypertensive Subjects

Journal of the American College of Cardiology

Volumn 53, Issue 10, 2009, Pages 884-890

  van Kimmenade, Roland R J ^a,b   Januzzi Jr , James L ^b   Bakker, Jaap A ^a   Houben, Alphonse J ^a   Rennenberg, Roger ^a   Kroon, Abraham A ^a   Crijns, Harry J G M ^a   van Dieijen Visser, Marja P ^a   de Leeuw, Peter W ^a   Pinto, Yigal M ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

BNP; kidney; natriuretic peptides; NT proBNP; renal function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ARTERIOGRAPHY; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL ARTERY;

BIOLOGICAL MARKERS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RENAL ARTERY; RENAL PLASMA FLOW;

EID: 60949091852     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.032     Document Type: Article

References (47)

1. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
2. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. Januzzi Jr. J.L., Sakhuja R., O'Donoghue M., et al. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 166 (2006) 315-320
4. Maisel A., Hollander J.E., Guss D., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 (2004) 1328-1333
5. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
6. McCullough P. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 4 (2003) S3-S12
7. Friedewald Jr. V.E., Burnett Jr. J.C., Januzzi Jr. J.L., Roberts W.C., and Yancy C.W. The editor's roundtable: B-type natriuretic peptide. Am J Cardiol 101 (2008) 1733-1740
8. Luchner A., Hengstenberg C., Lowel H., et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 39 (2002) 99-104
9. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 (2003) 571-579
10. Luchner A., Hengstenberg C., Lowel H., et al. NT-proBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points. J Card Fail 11 (2005) 21-27
11. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
12. Sonnenberg J.L., Sakane Y., Jeng A.Y., et al. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 9 (1988) 173-180
13. DeFilippi C., van Kimmenade R.R., and Pinto Y.M. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 101 (2008) 82-88
14. Vickery S., Price C.P., John R.I., et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 46 (2005) 610-620
15. Austin W.J., Bhalla V., Hernandez-Arce I., et al. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. Am J Clin Pathol 126 (2006) 506-512
16. Richards A.M., Nicholls M.G., Espiner E.A., et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 47 (2006) 52-60
17. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009
18. Parfrey P.S., Foley R.N., Harnett J.D., Kent G.M., Murray D.C., and Barre P.E. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11 (1996) 1277-1285
19. McDonagh T.A., Holmer S., Raymond I., Luchner A., Hildebrant P., and Dargie H.J. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6 (2004) 269-273
20. Alehagen U., Lindstedt G., Eriksson H., and Dahlstrom U. Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem 49 (2003) 1337-1346
21. van Kimmenade R., Januzzi Jr. J.L., Baggish A.L., et al. Amino-terminal pro-brain natriuretic peptide, renal function and outcomes in acute heart failure; re-defining the cardio-renal interaction?. J Am Coll Cardiol 48 (2006) 1621-1627
22. Schou M., Dalsgaard M.K., Clemmesen O., et al. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 99 (2005) 1676-1680
23. Goetze J.P., Jensen G., Moller S., Bendtsen F., Rehfeld J.F., and Henriksen J.H. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36 (2006) 8-15
24. Lainchbury J.G., Nicholls M.G., Espiner E.A., Ikram H., Yandle T.G., and Richards A.M. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Clin Sci (Lond) 95 (1998) 547-555
25. Richards A.M., Crozier I.G., Yandle T.G., Espiner E.A., Ikram H., and Nicholls M.G. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69 (1993) 414-417
26. Rutten J.H., Boomsma F., and van den Meiracker A.H. Higher renal extraction of ANP compared with NT-proANP, BNP and NT-proBNP. Eur J Clin Invest 36 (2006) 514-515
27. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., Doughty R.N., and Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 47 (1997) 287-296
28. Wierema T.K., Houben A.J., Kroon A.A., et al. Nitric oxide dependence of renal blood flow in patients with renal artery stenosis. J Am Soc Nephrol 12 (2001) 1836-1843
29. Fogteloo A.J., Meinders A.E., Pijl H., Kroon A.A., Frolich M., and De Leeuw P.W. Renal clearance of endogenous leptin in hypertensive humans with or without renal artery stenosis. Am J Physiol Endocrinol Metab 281 (2001) E400-E404
30. Ladefoged J. Measurements of the renal blood flow in man with the 133 xenon wash-out technique. A description of the method. Scand J Clin Lab Invest 18 (1966) 299-315
31. Devereux R.B., Casale P.N., Kligfield P., et al. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 57 (1986) 1388-1393
32. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
33. Carone F.A., Peterson D.R., Oparil S., and Pullman T.N. Renal tubular transport and catabolism of proteins and peptides. Kidney Int 16 (1979) 271-278
34. Maack T., Johnson V., Kau S.T., Figueiredo J., and Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16 (1979) 251-270
35. Clark W.R., and Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 13 Suppl 1 (2002) S41-S47
36. Hollenberg N.K., Adams D.F., Solomon H.S., Rashid A., Abrams H.L., and Merrill J.P. Senescence and the renal vasculature in normal man. Circ Res 34 (1974) 309-316
37. Fliser D., Zeier M., Nowack R., and Ritz E. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 3 (1993) 1371-1377
38. Kroll M.H., and Srisawasdi P. The clearance of BNP modeled using the NT-proBNP-BNP relationship. Biosystems 88 (2007) 147-155
39. Kemperman H., van den Berg M., Kirkels H., and de Jonge N. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 50 (2004) 1670-1672
40. Deschodt-Lanckman M., Michaux F., De Prez E., Abramowicz D., Vanherweghem J.L., and Goldman M. Increased serum levels of endopeptidase 24.11 ('enkephalinase') in patients with end-stage renal failure. Life Sci 45 (1989) 133-141
41. Kuhn M., Voβ M., Mitko D., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 64 (2004) 308-314
42. Andreassi M.G., Del Ry S., Palmieri C., Clerico A., Biagini A., and Giannessi D. Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. Eur J Heart Fail 3 (2001) 407-414
43. Jaffe A.S., Apple F.S., and Babuin L. Why we don't know the answer may be more important than the specific question. Clin Chem 50 (2004) 1495-1497
44. Vickery S., Webb M.C., Price C.P., John R.I., Abbas N.A., and Lamb E.J. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population. Nephrol Dial Transplant 23 (2008) 3546-3553
45. McKie P.M., Rodeheffer R.J., Cataliotti A., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 47 (2006) 874-880
46. Eguchi K., Matsui Y., Shibasaki S., et al. Changes in self-monitored pulse pressure correlate with improvements in B-type natriuretic peptide and urinary albumin in treated hypertensive patients. Am J Hypertens 20 (2007) 1268-1275
47. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663